JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Positive sharp wave origin: evidence supporting the electrode initiation hypothesis.

Muscle & Nerve 2007 September
This investigation analyzes the temporal characteristics of maximal depolarization times for three waveforms: end-plate spikes, fibrillation potentials, and positive sharp waves (PSWs) to provide support for the electrode initiation hypothesis of PSW induction. The maximal depolarization times for PSWs are documented to comprise two distinct populations conforming to relatively short and comparatively longer maximal depolarization times. Those PSWs with short maximal depolarization times were found to be equivalent to end-plate spike maximal depolarization times, whereas those with longer times were comparable to fibrillation potentials. The PSW group with shorter maximal depolarization times was encountered more frequently. The combination of two distinct groups of PSWs with respective times comparable to end-plate spikes and fibrillation potentials supports the hypothesis that the majority of PSWs originate at the recording electrode during insertion, whereas a smaller population of PSWs arises as propagating fibrillation potentials that block at the recording electrode. Subcutaneous compared to intramuscular recordings from denervated muscle document that the recording electrode is necessary to both record and produce PSWs. Hence, this study confirms the proposed hypothesis that the majority of observed PSWs represent a suprathreshold single muscle-fiber discharge induced by, and originating in close proximity to, a perielectrode crushed membrane that then propagate away from the electrode; a smaller population of PSWs conform to that of a blocked fibrillation potential.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app